Pharmaceutical Technology

MAY 26, 2023

Krystal Biotech has received approval from the US Food and Drug Administration for topical gene therapy VYJUVEK to treat dystrophic epidermolysis bullosa (DEB) in adults and in children aged six months and above. Topic sponsors are not involved in the creation of editorial content.

Food and Drug Administration 105

Food and Drug Administration FDA Manufacturing Food 105

pharmaphorum

OCTOBER 26, 2022

Topicals — creams, ointments, foams, and lotions applied directly to the affected areas of the skin — don’t get nearly as much TV time as their systemic biologic counterparts, the self-injectables with catchy theme songs, where the smiley and sleeveless walk confidently down the street and/or swim. Both are once-a-day treatments.

Side effects 94

Side effects Food and Drug Administration Patients Management 94

Pharmacy Times

OCTOBER 6, 2023

Ketamine topical cream may alleviate symptoms of PTSD without causing the adverse effects and abuse potential often associated with other forms of ketamine administration.

65

65

Pharmacy Times

JANUARY 9, 2024

Berdazimer topical gel, 10.3% (Zelsuvmi; Ligand Pharmaceuticals Inc) has been approved for the treatment of molluscum contagiosum in individuals aged 1 year and older.

FDA 58

FDA Pharmaceutical 58

Copyright Clearance Center

MARCH 9, 2023

The post Topics in Data Management Part II: The Need for Data Governance appeared first on Copyright Clearance Center.

Government 89

Government Management 89

PharmaTech

OCTOBER 12, 2023

The draft guidance document discusses quality considerations for topical ophthalmic drug products.

FDA 52

FDA 52

Pharmacy Times

FEBRUARY 29, 2024

Topical niacinamide stabilizes the skin's outer barrier, reducing water loss and improving moisture levels in the epidermis.

Patients 49

Patients 49

PM360

OCTOBER 27, 2022

a clinical-stage biopharmaceutical company focused on gene therapies for dermatological diseases, recently announced positive results from a Phase 3 clinical trial on its investigational compound Beremagene Geperpavec (B-VEC), a topical gene therapy designed to treat the debilitating skin condition dystrophic epidermolysis bullosa (DEB).

Safety 104

Safety Patients FDA Medical 104

PharmaVoice

JULY 11, 2022

Phil Brown, Dermavant’s chief medical officer, discusses VTAMA — the first topical cream approved for psoriasis in 25 years.

Marketing 98

Marketing Medical 98

MedReps

NOVEMBER 15, 2022

Attending a medical sales training program will teach you a number of helpful things, including these five crucial topics. Putting together an effective medical sales training program requires you to cover a number of different topics, all of which those budding sales reps need to know in order to be successful. 1) Sales Basics.

Medical sales 89

Medical sales Training Medical sales reps Sales 89

Pharmacy Times

MARCH 18, 2024

The FDA-approved topical and oral agent is currently indicated for adult patients with patterned alopecia.

Patients 52

Patients FDA 52

ALULA

APRIL 13, 2023

Recently I attended the Women in Leadership panel at the American Manufacturing Summit. The panel included senior leaders from Caterpillar, Cummins, The Boeing Company, Kimberly-Clark Corporation, Philips, and Johnson & Johnson.

Manufacturing 98

Manufacturing 98

Fierce Pharma

JANUARY 11, 2024

Dermavant’s topical cream Vtama, already on the market for plaque psoriasis as a steroid-free treatment, is compiling impressive data in pursuit of an FDA approval in atopic dermatitis (AD).

FDA 310

FDA Marketing 310

Clarivate

SEPTEMBER 15, 2022

Writing a great research paper is easier when you have a timely and focused topic. Keep reading for ocean research topics and keywords that branch across many different disciplines—from business to economics to the hard sciences. You will write a better paper if you care about the topic. Next steps for your ocean health topic.

Food 59

Food Management Government 59

Pharmaceutical Technology

JUNE 12, 2023

Patients with erectile dysfunction (ED) will now be able to access a topical treatment without the need for a prescription after the US Food and Drug Administration (FDA) greenlit Futura Medical’s Eroxon. The addition of a topical gel to pharmacy shelves expands treatment options available to those with ED.

Food and Drug Administration 52

Food and Drug Administration FDA Prescription Food 52

Fierce Pharma

JANUARY 24, 2024

It’s been four years since Japan Tobacco snagged approval in its home country for its topical JAK inhibitor delgoci | It’s been four years since Japan Tobacco snagged approval in its home country for its topical JAK inhibitor delgocitinib to treat atopic dermatitis.

Pharma 246

Pharma Patients 246

PharmaTech

SEPTEMBER 3, 2022

API permeation into the skin modulates the efficacy of topical treatments.

52

52

PharmaTech

FEBRUARY 2, 2023

Topical eye treatments can be beneficial for patients with a growing array of eye diseases, but only if taken appropriately.

Patients 52

Patients 52

PharmaTech

MAY 25, 2023

FDA has approved the first topical gene therapy product for treating wounds in patients with dystrophic epidermolysis bullosa.

FDA 52

FDA Patients 52

Fierce Pharma

OCTOBER 11, 2023

Fierce Pharma sits down with digital marketing leaders to discuss this year's most innovative topics at Digital Pharma East. Fierce Pharma sits down with digital marketing leaders to discuss this year's most innovative topics at Digital Pharma East. Learn more by watching the videos below.

Pharma 246

Pharma Marketing 246

Pharma Marketing Network

DECEMBER 6, 2021

NEW YORK, December 6 th , 2021 (PRNEWSWIRE) – Tap Native, the leading health-focused content discovery platform, today unveiled a list of the top 20 most popular health topics viewed by consumer audiences in 2021. million unique URLs across the top 100 largest health websites in its network to determine which topics were viewed most.

Healthcare 52

Healthcare Healthcare Engineering Leads 52

Fierce Pharma

MARCH 11, 2024

After a pair of approvals in recent years and as its sales continue to climb, Incyte's topical JAK inhibitor Opzelura is adding to its clinical case with trial results that demonstrate its benefits | The company presented positive data from a phase 2 study in mild-to-moderate hidradenitis suppurativa at the American Academy of Dermatology's (..)

Sales 289

Sales 289

pharmaphorum

AUGUST 31, 2022

Futura Medical’s development of a topical treatment for erectile dysfunction (ED) is approaching the finish line in the US, as the UK biotech reports confirmatory phase 3 data ahead of an FDA filing later this month. ” The post Futura eyes FDA filing as topical ED drug passes phase 3 test appeared first on.

FDA 52

FDA Side effects Prescription Medical 52

Fierce Pharma

DECEMBER 19, 2023

As the biopharma world readies for the turn of the calendar, the all-too-familiar topic of drug pricing once again presents an industry-wide overhang. drug prices coming out of Washington, the Biden administration is clearly emboldened on the topic. Based on the series of measures centered on U.S.

Biopharma 193

Biopharma Pharma 193

Fierce Pharma

NOVEMBER 14, 2023

As a result, Leerink Partners has slashed its sales projections for the nonsteroidal topical treatment. In the market, however, Vtama is struggling to catch on.

Sales 243

Sales Marketing 243

Pharmaceutical Commerce

DECEMBER 18, 2023

Arcutis Biotherapeutics said Zoryve foam will be widely available via key wholesaler and dermatology pharmacy channels by the end of January 2024.

FDA 52

FDA 52

Fierce Pharma

OCTOBER 11, 2023

In the race to develop nonsteroidal topical treatments for autoimmune skin conditions, Dermavant is charging toward the finish line—again. Dermavant has presented evidence that Vtama provides immediate and long-term relief from the severe itch condition pruritus, the most prevalent symptom of atopic dermatitis.

FDA 276

FDA 276

Fierce Pharma

OCTOBER 9, 2023

Fingerpaint Group’s Paul Hagopian sits down with Fierce Pharma to discuss what has become a hotly contested topic. Is it a silver bullet solution to productivity and personalization challenges?

Marketing 246

Marketing Pharma 246

Pharmaceutical Commerce

DECEMBER 20, 2023

Filsuvez is indicated to treat wounds associated with junctional epidermolysis bullosa and dystrophic epidermolysis bullosa in patients aged 6 months and older.

FDA 52

FDA Patients 52

Fierce Pharma

AUGUST 17, 2023

In this episode of "The Top Line," our Fierce reporters tackle topics like the trends we saw at Cannes Lions, the cancer drug shortage, and the top compensated CEOs in the industry. | This week on "The Top Line," we discuss the trends seen at Cannes Lions, the top compensated CEOs in the industry, and the cancer drug shortage

244

244

Pharmaceutical Technology

AUGUST 16, 2023

Eyenovia hopes for near-term revenue from the licencing deal, with APP13007’s PDUFA date set for 4 March 2024.

52

52

Pharmacy Times

NOVEMBER 23, 2022

As a new year approaches, pharmacists have so much to look back on and be grateful for, and a world of opportunity in front of them. Here are a few things to be ready for right away in 2023.

52

52

MedCity News

APRIL 17, 2024

In addition to panel discussions around some of the hottest topics in healthcare transformation, there is also a startup pitch contest, a presentation on government funding for startups and networking opportunities. The post Want to Connect with Innovative Healthcare Startups and Investors? Register for MedCity INVEST Today!

Healthcare 109

Healthcare Healthcare Government Networking 109

Fierce Pharma

OCTOBER 13, 2023

Now, the Danish dermatology specialist is peeling back the layers on those results.

Pharma 295

Pharma 295

pharmaphorum

JUNE 30, 2022

The post From trial design for patients to trial design with patients: a key topic at DIA ’22 appeared first on. Verst brings a holistic and comprehensive view of clinical research and champions the advanced use of real-world data, analytics, and technology to advance therapies for patients.

Patients 64

Patients Recruitment Transportation Healthcare 64

MedCity News

MARCH 19, 2024

At the MedCity INVEST conference, scheduled for May 21-22 at the Ritz Carlton in Chicago, health benefits in the context of value-based care will be one of several topics of discussion at the boutique healthcare investment event. Register today!

Healthcare 113

Healthcare Healthcare 113